Clorox’s Q2 FY2026 showed modest revenue and EPS declines amid ERP-related shipment timing, while the $2.25B GOJO (Purell) acquisition and steady cash flow helped spur a multiday stock rally. Investors are watching ERP normalization, synergy capture, and integration timing as near-term catalysts for CLX.
